Clinical trialPhase 2
AV-1959R vaccine in preclinical Alzheimer’s disease
NCT07827768
160 участников 55–80 лет, когнитивно сохранных, с биомаркерными признаками preclinical AD; randomized double-blind placebo-controlled.
No news refers to this card yet.
Scales
Identifiers
- NCT
- NCT07827768
Original sources
Details
- Phase
- Phase 2
A catalog card describes research; it is not medical advice. Decisions about treatment are made with a doctor.